In a study of the SALL4 gene promoter, a consensus TCF/LEF-binding site within a region of 31 bp was described, possibly playing a role in the stimulation of Wnt/β-catenin signaling in various cancers (including CRC) through direct β-catenin biding and oncogene action [76,78]. Here, SALL4 is linked to colorectal carcinoma.